This document provides information on the audiences of various science, technology, and healthcare newsletters from AZoNetwork Media Kit. It lists the number of subscribers for each newsletter as of January 2022, which range from over 1,000 subscribers to over 100,000 subscribers. It also provides overall audience metrics, including over 135 million annual unique users and nearly 1 million active subscribers. The document promotes AZoNetwork's wide range of newsletter topics across various industries.
Welcomed the challenge to give updates in Rheumatology under 10 minutes during the 2024 PCP Annual Convention.
The QR code to the compilation of references didn't work so here's the link https://drive.google.com/drive/folders/1cZUPyvey-lutM3jgslCrq-5oHakbM5Aw?usp=sharing
Welcomed the challenge to give updates in Rheumatology under 10 minutes during the 2024 PCP Annual Convention.
The QR code to the compilation of references didn't work so here's the link https://drive.google.com/drive/folders/1cZUPyvey-lutM3jgslCrq-5oHakbM5Aw?usp=sharing
Νικόλαος Κουρεντζής, Country Head Radiology-Ελλάδα, Κύπρος, Ισραήλ, Ρουμανία, Βουλγαρία, Μάλτα και Μολδαβία, Bayer
«Οι νέες προκλήσεις στην ιατρική απεικόνιση»
PPT: Medical Cyclotron Market to Witness Huge Growth during 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical cyclotron market reached a value of US$ 192.6 Million in 2021. Medical cyclotron represents a type of particle accelerator, wherein an alternating electric field propels a beam of charged units in a spiral pattern. This assists in producing protons and radioactive isotopes for medical imaging, diagnosis, and treatment of various cardiovascular disorders.
Health Datapalooza IV: June 3rd-4th, 2013
The State of the Art: Enterprise Data Use at the Point of Care
Moderator:
Janet Marchibroda, Director, Health Innovation Initiative, Bipartisan Policy Center
The new delivery models have made it clear- they need health information technology (IT) and data in order to succeed in providing high value health care. Many decision-makers and clinical staff are overwhelmed by or are looking for the evidence to support using the increasing amount and divergent types of data that can be leveraged at the enterprise level and point of care. Patient-generated data, open data streams, cost and quality information – how will it fit into the clinical workflow, and does it make a difference in operations and clinical outcomes? Join us for demos and a discussion of the state of the art.
Panel A (3:30-4:15pm): Enterprise-Level Data Analytics
Speakers:
Jack Challis, Chief Executive Officer & Co-Founder, CliniCast
Allen Kamer, Vice President Corporate Development and Marketing, Humedica
Jonathan Porter, Vice President Product Strategy, athenahealth
Eric Page, Chief Executive Officer, Amplify Health
Graham Gardner, Chief Executive Officer, Kyru.us
Panel B (4:15-5:00 pm): Data at the Point of Care
Speakers:
Jason Bhan, Executive Vice President & Co-founder, Medivo
Madhu Nutakki, Vice President of Digital Presence Technologies, Kaiser Permanente
Noah Craft, Chief Medical Officer, VisualDx
Michael Long, Chief Executive Officer, Lumeris
Omri Gottesman, CLIPMERGE, Mount Sinai School of Medicine
These sessions are eligible for continuing education credit.
Women's Health Diagnostics Market PPT: Overview, Dynamics, Trends, Segmentati...IMARC Group
The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
More Info:- https://www.imarcgroup.com/womens-health-diagnostics-market
The coronavirus pandemic of 2019–2020 is an infectious disease caused by extreme acute respiratory coronavirus syndrome 2 (SARS‐CoV‐2). The virus primarily spread among people when they closely meet each other. Due to the decreased immune-compromised state, cancer patients are at high risk. Through this whitepaper, we have enlighted about the effect of the COVID-19 on cancer patients.
Open Access is increasingly a determining part of the structures and processes of scholarly communication, particularly in the emerging open science modus operandi, which presupposes the opening of all research components. Currently, most scholarly communication instances, products and services refer to open access in some way. The bibliographic indexes started to identify open access articles. New publishers were created, most commercial publishers started to publish open access journals or offer authors the possibility to publish open access articles in subscription journals. Open access mega journals have appeared. In developing countries, open access journals predominate, with emphasis on the pioneering SciELO Program, publishing open access journals from 1998, four years before the Budapest Open Access Initiative declaration. The preprints modality with open access availability of manuscripts before evaluation and publication in journals grows and new tools appear. Several innovative models have emerged in recent years to promote open access to journal articles, such as library consortia or crowdfunding. There is still difficulty and resistance from publishers in developing financial models that enable open access, and the calculation of article processing charges (APC) remains opaque. But the main force that can make the universalization of open access viable is public policies, the best example being currently the European Commission’s Horizon 2020 program.
Before this landscape, this panel will analyze progress already achieved, the promising solutions and the persistent barriers in the routes towards the universalization of open access.
Syllabus
The classical open access modalities – gold route journals, green route, new models of open access financing, metrics on the status of open access, barriers to the universalization of open access, and open access policies.
Online Counselling with our best global directory of the India's leading trained and credentialed experts. Online counselling is convenient and effective.
Presentation from eHealth 2003 Conference in London, England, in the “eHealth and Patient Centred Care” session at 11:30 am on October 16.
http://www.brown2020.com
Dialysis Market PPT: Demand, Trends and Business Opportunities 2023-28IMARC Group
The global dialysis market size reached US$ 110.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 148.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.
More info:- https://www.imarcgroup.com/dialysis-market
Industry Focus Slide Share carousel.pdfFrank Barker
The Industry Focus eBook engages users and is available for sponsorship. Reach new audiencesfrom each speciic Life Science discipline. Establish trust and thought leadership by having your content appear alongside the most popular content of the year.
Check out the Lead Generation eBooks from the AZoNetwork. Collate your best-perfomrming content and drive traffic to the landing page. Reach new audiences and generate better leads.
Νικόλαος Κουρεντζής, Country Head Radiology-Ελλάδα, Κύπρος, Ισραήλ, Ρουμανία, Βουλγαρία, Μάλτα και Μολδαβία, Bayer
«Οι νέες προκλήσεις στην ιατρική απεικόνιση»
PPT: Medical Cyclotron Market to Witness Huge Growth during 2022-2027IMARC Group
According to the latest report by IMARC Group, the global medical cyclotron market reached a value of US$ 192.6 Million in 2021. Medical cyclotron represents a type of particle accelerator, wherein an alternating electric field propels a beam of charged units in a spiral pattern. This assists in producing protons and radioactive isotopes for medical imaging, diagnosis, and treatment of various cardiovascular disorders.
Health Datapalooza IV: June 3rd-4th, 2013
The State of the Art: Enterprise Data Use at the Point of Care
Moderator:
Janet Marchibroda, Director, Health Innovation Initiative, Bipartisan Policy Center
The new delivery models have made it clear- they need health information technology (IT) and data in order to succeed in providing high value health care. Many decision-makers and clinical staff are overwhelmed by or are looking for the evidence to support using the increasing amount and divergent types of data that can be leveraged at the enterprise level and point of care. Patient-generated data, open data streams, cost and quality information – how will it fit into the clinical workflow, and does it make a difference in operations and clinical outcomes? Join us for demos and a discussion of the state of the art.
Panel A (3:30-4:15pm): Enterprise-Level Data Analytics
Speakers:
Jack Challis, Chief Executive Officer & Co-Founder, CliniCast
Allen Kamer, Vice President Corporate Development and Marketing, Humedica
Jonathan Porter, Vice President Product Strategy, athenahealth
Eric Page, Chief Executive Officer, Amplify Health
Graham Gardner, Chief Executive Officer, Kyru.us
Panel B (4:15-5:00 pm): Data at the Point of Care
Speakers:
Jason Bhan, Executive Vice President & Co-founder, Medivo
Madhu Nutakki, Vice President of Digital Presence Technologies, Kaiser Permanente
Noah Craft, Chief Medical Officer, VisualDx
Michael Long, Chief Executive Officer, Lumeris
Omri Gottesman, CLIPMERGE, Mount Sinai School of Medicine
These sessions are eligible for continuing education credit.
Women's Health Diagnostics Market PPT: Overview, Dynamics, Trends, Segmentati...IMARC Group
The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
More Info:- https://www.imarcgroup.com/womens-health-diagnostics-market
The coronavirus pandemic of 2019–2020 is an infectious disease caused by extreme acute respiratory coronavirus syndrome 2 (SARS‐CoV‐2). The virus primarily spread among people when they closely meet each other. Due to the decreased immune-compromised state, cancer patients are at high risk. Through this whitepaper, we have enlighted about the effect of the COVID-19 on cancer patients.
Open Access is increasingly a determining part of the structures and processes of scholarly communication, particularly in the emerging open science modus operandi, which presupposes the opening of all research components. Currently, most scholarly communication instances, products and services refer to open access in some way. The bibliographic indexes started to identify open access articles. New publishers were created, most commercial publishers started to publish open access journals or offer authors the possibility to publish open access articles in subscription journals. Open access mega journals have appeared. In developing countries, open access journals predominate, with emphasis on the pioneering SciELO Program, publishing open access journals from 1998, four years before the Budapest Open Access Initiative declaration. The preprints modality with open access availability of manuscripts before evaluation and publication in journals grows and new tools appear. Several innovative models have emerged in recent years to promote open access to journal articles, such as library consortia or crowdfunding. There is still difficulty and resistance from publishers in developing financial models that enable open access, and the calculation of article processing charges (APC) remains opaque. But the main force that can make the universalization of open access viable is public policies, the best example being currently the European Commission’s Horizon 2020 program.
Before this landscape, this panel will analyze progress already achieved, the promising solutions and the persistent barriers in the routes towards the universalization of open access.
Syllabus
The classical open access modalities – gold route journals, green route, new models of open access financing, metrics on the status of open access, barriers to the universalization of open access, and open access policies.
Online Counselling with our best global directory of the India's leading trained and credentialed experts. Online counselling is convenient and effective.
Presentation from eHealth 2003 Conference in London, England, in the “eHealth and Patient Centred Care” session at 11:30 am on October 16.
http://www.brown2020.com
Dialysis Market PPT: Demand, Trends and Business Opportunities 2023-28IMARC Group
The global dialysis market size reached US$ 110.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 148.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.
More info:- https://www.imarcgroup.com/dialysis-market
Industry Focus Slide Share carousel.pdfFrank Barker
The Industry Focus eBook engages users and is available for sponsorship. Reach new audiencesfrom each speciic Life Science discipline. Establish trust and thought leadership by having your content appear alongside the most popular content of the year.
Check out the Lead Generation eBooks from the AZoNetwork. Collate your best-perfomrming content and drive traffic to the landing page. Reach new audiences and generate better leads.
AZoNetwork has 19 unique life science newsletters. From Antibodies and Analytical Chromatography to Toxicology and Zoonotic diseases, AZoNetwork has the right life science audience for you.
Sponsor a targeted industry year in review on AZoNetwork. Place your content within our most viewed articles across: Infectious Diseases, AFM, COVID-19, Tribology, Spectroscopy and much more.
Reach scientists working in Life Sciences, Antibodies, Biotechnology, Cell Biology, Drug Discovery, Flow Cytometry, Genomics, Healthcare, Laboratory...
State of scientific purchasing webinarFrank Barker
The team looked at the latest scientific buying trends in 2021.
100+ scientific purchasing teams were surveyed in order to produce this market report.
Our goal was simply, to provide sales and marketing professionals with the latest insight into scientific buying trends in 2021.
Lead Scoring - Aligning Sales and MarketingFrank Barker
Lead scoring is imperative for Sales and Marketing teams to prioritise time and resources. See how implicit and explicit data combine to give you a quantifiable lead score.
2 years ago I bought a VISA so I could fly to the U.S. for Pittcon 2019 in Philadelphia.
In March 2020, we were lucky to be in Chicago’s McCormick centre shortly before it got turned into a field hospital.
This year instead of New Orleans, we have gone virtual… I’ve even got my very own avatar on the booth - Where’s Wally!
Hats off to the Pittcon team for getting the content together for what is set to be a fantastic show with over 170 exhibitors, countless posters and keynote speakers.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
8. Osteoporosis 2,013 Subscribers
Diabetes 8,147 Subscribers
Gastroenterology 5,562 Subscribers
Rheumatology 5,448 Subscribers
Endocrinology 2,742 Subscribers
Cholesterol 2,589 Subscribers
Radiology 5,634 Subscribers
Skin Cancer 1,942 Subscribers
Bladder Cancer 1,001 Subscribers
Bowel Cancer 1,784 Subscribers
Breast Cancer 6,600 Subscribers
Cervical Cancer 20,150 Subscribers
Oncology 12,181 Subscribers
Prostate Cancer 3,186 Subscribers
AZoNetwork Media Kit 10
Rheumatology
Rheumatology
Cancer
Cancer
Gastroenterology
Gastroenterology
Metabolism
Metabolism
Number of subscribers as of Jan 2022
9. Pregnancy / Maternal Health 6,508 Subscribers
Medical Devices 113,013 Subscribers
Women's Health 60,173 Subscribers
Nanomedicine 3,118 Subscribers
A.I. In Healthcare 56,094 Subscribers
Genetics 24,360 Subscribers
Hematology 9,559 Subscribers
COVID-19 35,774 Subscribers
HIV / AIDS 4,631 Subscribers
Infectious Diseases 90,170 Subscribers
Clinical & Lab Diagnostics 112,743 Subscribers
AZoNetwork Media Kit 11
Women's Health
Women's Health
Infectious Diseases
Infectious Diseases
Translational Medicine
Translational Medicine
Technology
Technology
Number of subscribers as of Jan 2022
10. AZoNetwork Media Kit 12
We run weekly, biweekly & monthly newsletters. To offer a full overview of our newsletter
network, we have created our Editorial Calendar 2022. See all our outgoing NL topics and
International World Days at a glance.
Editorial Calendar
We currently oversee 981 newsletter editions from 99 active newsletters, across 6 broad
categories with subjects ranging from Automotive, Agritech and Antibodies through to
XRF and Infectious Zoonotic Diseases.
7 8 9 10 11 12
13
Nursing
Oncology
Semiconductors
Respiratory Disease International Women's Day
Mining
Pregnancy/Maternal Health
Graphene & Nanotubes
Mechanical & Physical
Properties Testing
Spectroscopy
Advanced Alloys
Clinical & Lab Diagnostics
Fuel & Lubricant Analysis
Automation & Robotics
Life Science Microscopy
Sensors
Dermatology
Nutrition
Metabolomics
Non-Destructive Testing
Aerospace
Thin Films
Prostate Cancer
No Smoking Day
Monday Tuesday Wednesday Thursday Friday Sat/Sun
M A R C H
11. AZoNetwork Media Kit 13
Editorial Calendar
Head over to our Editorial Calendar to kickstart your
content strategy.
Just type out the newsletters you are interested in to
see when they are scheduled to send.
View the calendar
Plan your year of content with us.